TCT 2023
Advertisement
Dr. Lichaa details his presentation from TCT 2023, which covers tips and tricks for dealing with peripheral challenges.
In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years.
Dr. Nabil Dib discusses his UltraNav Transseptal Catheter System.
Patients with severe aortic stenosis who have low surgical risk have better outcomes using TAVR compared with SAVR.
Researchers analyzed the long-term impact of TAVR on coronary arteries and cardiac hemodynamics.
A combination therapy of a statin and ezetimibe significantly reduces cardiovascular events in patients undergoing PCI.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.